Stockreport

Akers Biosciences Jumps On COVID-19 Vaccine Progress, Will Remain Volatile [Seeking Alpha]

AKERS BIOSCIENCES INC COMMON S  (AKER) 
US:NASDAQ Investor Relations: akersbio.com/investor-center
PDF SummaryThe licensing deal between Akers Biosciences and Premas Biotech is already starting to show promise.Together, the companies are working to find a vaccine to treat [Read more]